China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
CN |
|
Mattel Inc
NASDAQ:MAT
|
US |
Wall Street
Price Targets
Price Targets Summary
China National Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 35.56 CNY with a low forecast of 35.21 CNY and a high forecast of 36.6 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China National Medicines Corp Ltd's stock price target?
Price Target
35.56
CNY
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 35.56 CNY with a low forecast of 35.21 CNY and a high forecast of 36.6 CNY.
What is China National Medicines Corp Ltd's Revenue forecast?
Projected CAGR
4%
For the last 13 years the compound annual growth rate for China National Medicines Corp Ltd's revenue is 16%. The projected CAGR for the next 4 years is 4%.
What is China National Medicines Corp Ltd's Operating Income forecast?
Projected CAGR
32%
For the last 13 years the compound annual growth rate for China National Medicines Corp Ltd's operating income is 19%. The projected CAGR for the next 2 years is 32%.
What is China National Medicines Corp Ltd's Net Income forecast?
Projected CAGR
4%
For the last 13 years the compound annual growth rate for China National Medicines Corp Ltd's net income is 17%. The projected CAGR for the next 3 years is 4%.